Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06893536

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Patients with pancreatic adenocarcinoma are frequently in a situation of malnutrition, in a context of functional alteration of the digestive tract, and hypercatabolism.

As a result, nutritional support is frequently necessary perioperatively, but currently does not follow a specific protocol, and without coordination.

It then appears the need to evaluate the prevalence of malnutrition, its impact on perioperative morbidity and mortality, and current management methods.

Depending on the findings, subsequent interventional studies will be carried out on the subject, exploring the different modalities of artificial nutrition.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pancreatic Adenocarcinoma Malnutrition Nutrition Disorders Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de Chirurgie Viscérale et Digestive - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Arne KOCK, MD

SUB_INVESTIGATOR

Zineb CHERKAOUI, MD

CONTACT

[email protected]

33 3 69 55 13 15

Zineb CHERKAOUI, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major subject (≥18 years old)
  • Subject with pancreatic adenocarcinoma authenticated by pathology
  • Subject candidate for curative surgical treatment
  • Subject operated on in the visceral and digestive surgery department, NHC Strasbourg, during the period from January 1, 2018 to December 31, 2022
  • Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.

Exclusion criteria

  • Subject having expressed opposition to participating in the study
  • Subject presenting a metastatic form or one not accessible to surgical treatment considered curative of pancreatic adenocarcinoma
  • Subject under guardianship or curatorship
  • Subje

Treatment and study plan

Primary outcomes

  1. Study of the Severity of Perioperative Malnutrition in Pancreatic Adenocarcinoma

    Time frame: Up to 1 year

    The CCI score measures a patient's postoperative outcome based on the number and severity of complications occurring on a scale of 0 to 100:

    0: No complications 100: Death

Study contacts

Contact information is provided by the study sponsor or research team.

Zineb CHERKAOUI, MD

CONTACT

[email protected]

33 3 69 55 13 15

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: PAAD

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Mar 25, 2025
Registry last updated
Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.